#WCIRDC23
CME Conference on December 7-9, 2023
Hilton Universal Hotel Los Angeles
555 Universal Hollywood Dr, Universal City, CA 91608
Virtual Poster Hall
21st WCIRDC Accepted Abstracts 2023
Abstracts will be published in the Metabolism Journal
Editor-in-Chief: Christos S. Mantzoros, MD, DSc, PhD h.c. mult.
#0004
Prevalence of kidney and Hepatic Dysfunction, and Outcomes in Hospitalized Patients With COVID-19 Infection in SBA region (west of Algeria)
Author/s:
Demmouche Abbassia*, Abdallah Touati Djihène, Bouazza Sofiane ; Belmous Asmaa ; Bekhadda Hadjer : Itatahine Amina ; Mai Hicham
Organizations/Affiliations:
Biotoxicology laboratory, Department of Biology, Faculty of Natural Sciences and life-Djillali Liabes University of Sidi Bel Abbes, Algeria
Email Contact:
demmoucheabbassia@yahoo.fr
#0005
Semaglutide and lanifibranor Differentially Alter NASH and Liver Fibrosis in Diet-Induced Obese Hamsters With or Without Free Access to Alcohol
Author/s:
Francois Briand, Ph.D, Estelle Grasset, Ph.D, Natalia Breyner, Ph.D, Thierry Sulpice, Ph.D
Organizations/Affiliations:
PHYSIOGENEX
E-Mail Contact:
f.briand@physiogenex.com
#0008
Humanistic and Economic Burden of Patients With Cardiorenal Metabolic (CRM) Conditions: A Systematic Literature Review
Author(S): 1. Keith C. Ferdinand, MD; 2. Keith C. Norris, MD PhD; 3. Helena W. Rodbard, MD; 4. Jennifer M. Trujillo, PharmD
Organization/Affiliation:
1. Tulane University School of Medicine, Cardiology Section, New Orleans, LA; 2. Department of Medicine, Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, Los Angeles, CA; 3. Endocrine and Metabolic Consultants, Rockville, MD; 4. Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO
Email Contact:
paul.lidbury@envisionpharma.com
#0009
Healthcare Professionals’ Perceptions of Obesity & Agonists of the Glucagon,
GLP-1 & GIP Receptors
Author(S): 1. W. Timothy Garvey, MD; 2. Cathy D. Mahle, PhD; 3. Robert F. Kushner, MD
Organization/Affiliation
1. University of Alabama at Birmingham, Birmingham, AL, USA; 2. Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA; 3. Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Email Contact:
#0013
Levels of Biomarkers of Fibrosis in Patients with Diabetes Mellitus Type 2
Author(S): K.Tchaava, N.Gegeshidze, N.Ninashvili, T.Giorgadze, N.Kilasonia
Organization/Affiliation:
Tbilisi State Medical University, Georgian Technical University, Georgia
Organization/Affiliation
Tbilisi State Medical University, Georgian Technical University, Georgia
Email Contact:
#0015
Risk of Obesity, Diabetes, Insulin Resistance, and Dyslipidemia Among Irritable Bowel Syndrome Patients.
Author(S): Yomna E. Dean 1, Jose Jonathan Loayza Pintado 2, Lucy L. Nale 3, Samah S. Rouzan 1, Ahmed Abbas 4, Mohamed Doma 1, Abdulla M. Aboushaira 1, Farah Alkasajy 5, Ahmed A. Ghanem 6, Vinayak Mahesh Patil 7, Yana Gordeyeva 8, Karam R. Motawea 1, Masako Lien Le 8, Adham Galal 1, Laura Cicani 9, Raneem Mohamed Atta 1, Sameh Samir Elawady 10, Lamya Alzabidi 11, Ahmed Soliman 12, Tamer Mady 13, Hani Aiash 14
Organization/Affiliation:
1: Alexandria University 2: Universidad de San Martín de Porres 3: Windsor University School of Medicine 4: Zagazig university 5: Hashemite University 6: Mansoura University 7: Karnataka Institute of Medical Sciences 8: Poznan University of Medical Sciences 9: International University of Health Sciences 10: Neuro-endovascular Surgery Department, Medical University of South Carolina (MUSC) 11: Faculty of Medicine and Health Sciences, Sanaa University 12: Ain Shams University 13: International American University College of Medicine 14: SUNY Upstate Medical University
Email Contact:
#0018
Low Muscle Strength as a Risk Factor for Non-Alcoholic Fatty Liver Disease in Different Metabolic Subgroups
Author(S):
Hye-Sun Rho, Whan-Seok Choi
Organization/Affiliation:
Department of Family Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Main Contact Person Name
Email Contact:
#0019
Association of Serum Vitamin D Level and Type 2 Diabetes with Nonalcoholic Fatty Liver Disease
Author/s:
Maosheng Lee1,2, Siping Peng1,2, Xiaohui Xiao2, Zengying Li1,2, Hengxia Zhao1,2, Huilin Li1,2*
Organizations/Affiliations:
The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine
E-Mail Contact:
realsmile365@163.com
#0022
Maternal Dehydration Contributes to the Development of Salt Sensitivity of Blood Pressure (SSBP) in Offspring, with its Influence Likely Tied to an Elevation in Vasopressin Secretion.
Author(S):
Kim Y-B, PhD, Jung WW, PhD, Jin X, MD, PhD., Kang HK, MS, Kim YI, PhD
Organization/Affiliation:
Department of Physiology and Neuroscience Research Institute, Korea University College of Medicine, Seoul 02841, Republic of Korea
Email Contact:
#0023
A Phase II, randomized, double-blind, placebo-controlled, dose-finding study of survodutide (BI 456906) in people living with overweight/obesity
Author(S):
1. M Carel W Le Roux, BChB, MSC, FRCP, FRCPath, PhD; 2. Oren Steen, MD, FRCPC; 3. Kathryn J Lucas, MD; 4. Elena Startseva, MD, MBA; 5. Luiza Borowska MD; 6. Anna Unseld, Dipl Stat
Organization/Affiliation:
1. School of Medicine, St. Vincent's University Hospital and University College Dublin, Dublin, Ireland; 2. LMC Diabetes & Endocrinology, Toronto, Ontario, Canada; 3. Diabetes & Endocrinology Consultants PC, Morehead City, NC, USA; 4. Boehringer Ingelheim International GmbH, Ingelheim, Germany; 5. Boehringer Ingelheim International GmbH, Ingelheim, Germany; 6. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach/Riss, Germany
Email Contact:
#0037
Comparison of Glucose and Insulin Profile Between Normal and Prediabetic Subjects
Author/s:
Ava S Kumar*, Joseph W Babiarz
Organizations/Affiliations:
Aspirus Wausau Hospital, Wausau, WI, *DC Everest High School, Weston, WI
E-Mail Contact:
avakumar@icloud.com
#0039
Diabete and Covid 19 in SBA Region ( West of Algeria)
Author/s:
Demmouche Abbassia*, Belmous Asmaa ; Bouazza Sofiane ; Abdallah Touati Djihène,
Organizations/Affiliations:
Biotoxicology laboratory, Department of Biology, Faculty of Natural Sciences and life-Djillali Liabes University of Sidi Bel Abbes, Algeria
E-Mail Contact:
demmoucheabbassia@yahoo.fr
#0046
A Phase II, randomized, double-blind, placebo-controlled, dose-finding study of survodutide (BI 456906) in people living with overweight/obesity
Author(S):
1. M Carel W Le Roux, BChB, MSC, FRCP, FRCPath, PhD; 2. Oren Steen, MD, FRCPC; 3. Kathryn J Lucas, MD; 4. Elena Startseva, MD, MBA; 5. Luiza Borowska MD; 6. Anna Unseld, Dipl Stat
Organization/Affiliation:
1. School of Medicine, St. Vincent's University Hospital and University College Dublin, Dublin, Ireland; 2. LMC Diabetes & Endocrinology, Toronto, Ontario, Canada; 3. Diabetes & Endocrinology Consultants PC, Morehead City, NC, USA; 4. Boehringer Ingelheim International GmbH, Ingelheim, Germany; 5. Boehringer Ingelheim International GmbH, Ingelheim, Germany; 6. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach/Riss, Germany
Email Contact:
#0047
Effect of empagliflozin on all-cause hospitalization in EMPA-KIDNEY
Author(S):
Anastasia Uster MD,1 Nihar Desai MD,2 Sankar D Navaneethan MD,3 Egon Pfarr MSc,1 Anna Rita Mazo MD1
Organization/Affiliation:
1) Boehringer Ingelheim International GmbH, Ingelheim-am-Rhein, Germany 2) Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA 3) Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Email Contact:
#0048
Sodium-dependent glucose transporter 2 inhibitor alleviates renal lipid deposition and improves renal oxygenation levels in newly diagnosed type 2 diabetes mellitus patients: a randomized controlled trial
Author(S):
Yunqi Wu, M.M., Li Zhang, M.B., Haizhen Sun, M.D., Guangyang Ma, M.D., Ph.D, Shan Lu, M.D., Saijun Zhou, M.D., Pei Yu, M.D.
Organization/Affiliation:
1.NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, China 2.Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University,Tianjin 300134, China
Email Contact:
#0052
C3aR1 on Beta Cells Preserves Beta Cell Function and Glucose Homeostasis in Diabetic Mice by Decreasing Metabolic Stress and Dedifferentiation
Author/s:
Renan Lima PhD, Ankit Gilani PhD, Lisa Stoll PhD, Eric Cortada PhD, Edwin Homan MD, PhD, Kou Ang Li, Deanndria Singleton, Tint Tha Ra Wun, James C. Lo MD, PhD
Organizations/Affiliations:
Weill Center for Metabolic Health, Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
E-mail Contact:
rpl4002@med.cornell.edu
#0057
Effect of Finerenone on the Incidence of Hypokalemia in Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis
Author/s:
Bertram Pitt, MD,1; Rajiv Agarwal, MD,2; Stefan D. Anker, MD,3; George L. Bakris, MD,4; Peter Rossing, MD,5,6; Luis Ruilope, MD,7-9; Charles A. Herzog, MD,10; Barry H. Greenberg, MD,11; Robert Pecoits-Filho, MD,12,13; Faiez Zannad, MD,14; Marc Lambelet, Dipl Math,15; Robert Lawatscheck, MD,16; Andrea Scalise, MD,17; Gerasimos Filippatos, MD,18; Asia Quan, PharmD,19; on behalf of the FIDELIO-DKD and FIGARO-DKD Investigators
Organizations/Affiliations:
1. Department of Medicine, University of Michigan School of Medicine Ann Arbor, MI, USA; 2. Indiana University School of Medicine and Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA; 3. Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité–Universitätsmedizin, Berlin, Germany; 4. Department of Medicine, University of Chicago Medicine, Chicago, IL, USA; 5. Steno Diabetes Center Copenhagen, Herlev, Denmark; 6. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; 7. Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain; 8. CIBERCV, Hospital Universitario 12 de Octubre, Madrid, Spain; 9. Faculty of Sport Sciences, European University of Madrid, Madrid, Spain; 10. Cardiology Division, Department of Internal Medicine, Hennepin Healthcare/University of Minnesota, Minneapolis, MN, USA; 11. University of California San Diego, La Jolla, CA, USA; 12. Arbor Research Collaborative for Health, Ann Arbor, MI, USA; 13. School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil; 14. Henri Poincaré University, Nancy, France; 15. Chrestos Concept GmbH & Co. KG, Essen, Germany; 16. Cardiology and Nephrology Clinical Development, Bayer AG, Berlin, Germany; 17. Pharmaceutical Development, Bayer Hispania S.L., Barcelona, Spain; 18. National and Kapodistrian University of Athens, School of Medicine, Department of Cardiology, Attikon University Hospital, Athens, Greece; 19. Bayer US LLC, Whippany, NJ, USA
Email Contact:
asia.quan@bayer.com
#0058
Effect of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Anemia Status: A FIDELITY Analysis
Author/s:
Ajay Singh, MBBS,1; Stefan D. Anker, MD,2,3; Gerasimos Filippatos, MD,4; Bertram Pitt, MD,5; Peter Rossing, MD,6,7; Luis M. Ruilope, MD,8-10; Alfredo E. Farjat, PhD,11; Glen James, PhD,12; Youssef M.K. Farag, MD,PhD,13; Luke Roberts, MBBS PhD,14; George L. Bakris, MD,15; Tram Knecht, PharmD,13; on behalf of the FIDELIO-DKD and FIGARO-DKD Investigators
Organizations/Affiliations:
1. Renal Division, Harvard Medical School, Harvard University, Boston, MA, USA; 2. Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Berlin, Germany;3. Institute of Heart Diseases, Wrocław Medical University, Wrocław, Poland; 4. National and Kapodistrian University of Athens, School of Medicine, Department of Cardiology, Attikon University Hospital, Athens, Greece; 5. Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA; 6. Steno Diabetes Center Copenhagen, Herlev, Denmark; 7. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; 8. Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain; 9. CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain; 10. Faculty of Sport Sciences, European University of Madrid, Madrid, Spain; 11. Research and Development, Clinical Data Sciences and Analytics, Bayer PLC, Reading, UK; 12. Integrated Evidence Generation and Business Innovation, Bayer PLC, Reading, UK; 13. Cardiovascular and Renal United States Medical Affairs, Bayer U.S. LLC, Whippany, NJ, USA; 14. Clinical Development, Bayer PLC, Reading, UK; 15. Department of Medicine, University of Chicago Medicine, Chicago, IL, USA
E-mail Contact:
tram.knecht@bayer.com
#0060
Pathophysiology of Insulin Resistance: Connecting the Dots
Author(S):
Suresh N. Shinde,MD.
Organization/Affiliation:
Academy of Continuing Medical Education & research, Pune,India; Poona Hospital & Research Centre, Pune, India
Email Contact:
#0061
Prevalence and Clinical Characteristics of Patients with Transthyretin Amyloidosis in the United States and Japan: Results from the OverTTuRe Study
Author/s:
Jason Wright (Pharm.D.), Christian S. Alvarez (Ph.D.), Lai San Hong (Ph.D.), Krister Järbrink (Ph.D.), Neela Kumar(Ph.D.), Christina Pao (Ph.D.), Eric Wittbrodt (Pharm.D.), Shun Kohsaka (M.D.)
Organizations/Affiliations:
AstraZeneca
E-mail Contact:
#0064
Relationship between myeloperoxidase and metabolic syndrome at older patients
Author(S):
Gianina Ioana Constantin1, Simona Opris1, Catalina Monica Pena1
Organization/Affiliation:
1“Ana Aslan” National Institute of Gerontology and Geriatrics, Bucharest, Romania
Email Contact:
#0071
FIGARO-BM, a Biomarker Study of FIGARO-DKD, Reveals New Insights Into the Mode-of-Action of Finerenone
Author/s:
Mario Berger, PhD,1; Tram Knecht, PharmD,2; Lydia Christopher, BSc,3; Laura Goea, PhD,1; Peter Kolkhof, PhD,1; Aidan MacNamara, PhD,1; Richard Nkulikiyinka, MD,1; Andrea Scalise, MD,4; Adam Skubala, PhD,1; Sebastian Voss, PhD,5; Katja Rohwedder, MD,6; Joachim H. Ix, MD,7; Faiez Zannad, MD, PhD,8; Peter Rossing, MD, DMSc,9; Hiddo J. L. Heerspink, PhD,10
Organizations/Affiliations:
1. Bayer AG, Pharmaceuticals, R&D, Wuppertal/Berlin, Germany; 2. Bayer US LLC, Cardiovascular and Renal United States Medical Affairs, Whippany, New Jersey, USA; 3. Bayer UK, Cardiology, Reading, UK; 4. Bayer Hispania SL, Pharmaceutical Development, Barcelona, Spain; 5. CHRESTOS Concept GmbH & Co. KG, Essen, Germany; 6. Bayer AG, Pharmaceuticals, Medical Affairs, Berlin, Germany; 7. UCSD, Department of Medicine, San Diego, California, USA; 8. Université de Lorraine, Nancy, France; 9. Steno Diabetes Center Copenhagen, Herlev, and University of Copenhagen, Copenhagen, Denmark; 10. University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands
E-Mail Contact:
tram.knecht@bayer.com
#0072
Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Diuretic Use: A FIDELITY Analysis
Author/s:
Robert J. Mentz, MD,1; Stefan D. Anker, MD,2 Bertram Pitt, MD,3; Peter Rossing, MD DMSc,4,5; Luis M. Ruilope, MD,6-8; Martin Gebel, PhD,9; Peter Kolkhof, PhD,10; Robert Lawatscheck, MD,11; Katja Rohwedder, MD,12; George L. Bakris, MD,13; Asia Quan, PharmD,14; on behalf of the FIDELIO-DKD and FIGARO-DKD Investigators
Organizations/Affiliations:
1. Department of Medicine, Duke University School of Medicine, Durham, NC, USA; 2. Department of Cardiology (CVK) of German Heart Center Charité and Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin, Berlin, Germany; 3. Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA; 4. Steno Diabetes Center Copenhagen, Herlev, Denmark; 5. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; 6. Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain; 7. CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain; 8. Faculty of Sport Sciences, European University of Madrid, Madrid, Spain; 9. Statistics & Data Insights, Bayer AG, Wuppertal, Germany; 10. Research & Early Development, Bayer AG, Wuppertal, Germany; 11. Clinical Research, Bayer AG, Berlin, Germany; 12. Medical Affairs, Bayer AG, Berlin, Germany; 13. Department of Medicine, University of Chicago Medicine, Chicago, IL, USA; 14. Cardiorenal Medical Affairs, Bayer US LLC, Whippany, NJ, USA
E-mail Contact:
asia.quan@bayer.com
#0077
Single-dose GLP-1-based Pancreatic Gene Therapy Maintains Weight Loss After Semaglutide Withdrawal in a Murine Model of Obesity
Author(S):
Alice Liou Fitzpatrick, Suya Wang, Emily Cozzi, Randy Seeley, Jay Caplan, Timothy Kieffer, Harith Rajagopalan
Organization/Affiliation:
Fractyl Health, Inc.
Email Contact:
#0084
The Impact of Processing Methods on Free Fatty Acids Measurements in Type 2 Diabetes
Author(S)
Abigail Epstein, Medical Student¹*, Raquel Poliwoda, RN¹*, Welbeck Sowah, MA¹, Minka Chikolareva, RN, MS, MBA¹, Oana Sandu, MD¹, *First Author, ¹Albert Einstein College of Medicine, Bronx, NY
Organization/Affiliation
¹Albert Einstein College of Medicine
Email Contact:
#0096
Cardiometabolic Risk Factors in Type 2 Diabetes Persons Evaluated by Continuous Glucose Monitoring
Author/s:
Andreea Morosanu, MD, PHD, Assoc. Prof., Magdalena Morosanu, MD, PHD, Assoc. Prof.
Organizations/Affiliations:
1 Diamed Obesity SRL, Galaţi – Department of Diabetes, Nutrition and Metabolic Diseases, 2 "Dunarea de Jos" University of Galati, Crossborder Faculty
E-mail Contact:
2022 Accepted Abstracts
Abstracts will be published in the Metabolism Journal
Editor-in-Chief: Christos S. Mantzoros, MD, DSc, PhD h.c. mult.
#0001
Value of Breastfeeding in Pregnant with Gestational Diabetes Mellitus
Abdelghani S.M
#0002
Syringic acid ameliorates experimental diabetic nephropathy in rats through its antiinflammatory, anti-oxidant and anti-fibrotic effects by suppressing Toll like receptor-4 pathway
Omar M. Zabad* 1 , Yara A. Samra1 , Laila A. Eissa* 1
#0004
Non-HDL-cholesterol and atherogenicity in type 2 diabetes mellitus patients
Simona Opriş*, Gianina-Ioana Constantin
#0005
Factors associated with hepatic steatosis in adult Greek subjects with type 2 diabetes mellitus
Angeliki Meritsi, MD1, Emanuel Manesis MD2, Marina Noutsou1 Panagiotis Koussis3, Stamatia Rapti4, Dimitra Latsou5, Ioannis Tsorlalis1, Eustathios Tsitsopoulos4, Hariklia Moshoyianni6, Spilios Manolakopoulos7, Dimitrios Pektasides8, Anastasia Thanopoulou, MD1
#0006
Blood based biomarkers as non-invasive screening tools for hepatic fibrosis in subjects with Type 2 Diabetes Mellitus.
Angeliki Meritsi, MD1, Dimitra Latsou2, Ioannis Tsorlalis1, Marina Noutsou1, Emanuel Manesis MD3, Ilias Gatos4, Ioannis Theotokas MD4, Pavlos Zoumpoulis MD4, Stamatia Rapti5, Eustathios Tsitsopoulos5, Hariklia Moshoyianni6, Spilios Manolakopoulos MD7, Dimitrios Pektasides MD8, Anastasia Thanopoulou, MD1
#0007
Development of Cardiac specific Neurohormonal based diagnostic marker for Diabetes linked cardiac failure
Iram Murtaza, Iram Mushtaq, Ayesha Ishtiaq
#0008
miRNAs and Endothelin: A potential nexus in the roadmap for diabetes linked cardiac complications therapeutic strategy
Ayesha Ishtiaq, Iram Mushtaq, Iram Murtaza
#0009
FTO, PPAR-γ and ABCC8 gene variation and hypertension as determinants of cardiometabolic risk in CVD patients
Kanwal Rehman1,2,, Sania Niaz2, Ayesha Tahir2, Komal Jabeen1,2, Muhammad Sajid Hamid Akash3
#0010
Insulin resistance susceptibility is associated with BPA exposure
Muhammad Sajid Hamid Akash1, Abdul Qader1, Kanwal Rehman2
#0011
Long-term exposure of Bisphenol A impairs metabolism and develop insulin resistance
Kanwal Rehman1, Abdul Qader2, Muhammad Ejaz ul Haq2, Muhammad Sajid Hamid Akash2
#0012
The use of Rozuvastatin (Rozuvastatin Denk) and Metformin combination in women with abdominal obesity
K.Tchaava, N.Gegeshidze ,M.Shavdia, N.Ninashvili, M.Gogiashvili
#0013
Comparison of New-Onset Diabetes Mellitus among Patients with Atrial Fibrillation or Atrial Flutter
WEI SYUN HU
#0014
Role of CHA 2 DS 2-VASc score in predicting new-onset atrial fibrillation in patients with type 2 diabetes mellitus with and without hyperosmolar hyperglycaemic state: real-world data from a nationwide cohort
WEI SYUN HU
#0015
A nationwide cohort study of the role of CHADS 2 score in predicting lower extremity amputation and death among patients with peripheral arterial occlusive disease
WEI SYUN HU
#0016
Diabetes and Cancer. How far off cancer-screening uptake among female diabetic patient?
Noraidatulakma Abdullah1,2, Azmawati Nawi1,3, Mohd Arman Kamaruddin1, Nazihah Jalal1, Rahman Jamal1.
#0017
Demographics of COVID 19 admitted patients and obesity: a retrospective study
Vlachopoulou M., Sarantis N., Chatzis G.
#0018
Sitagliptin on carotid intima-media thickness in type 2 diabetes and hyperuricemia patients: A subgroup analysis of the PROLOGUE study
Yipin Zhao, Zebin Lin, Qingwei Chen
#0019
A review on the role of Phytosterol enriched food in anticancer activity
Anup Ghosal
#0020
Reversing Time: A possibility through chronobiology EFFECT OF TINE RESTRICTED MEAL INTAKE ON ANTHROPOMETRIC AND BIOCHEMICAL PARAMETERS IN TYPE 2 DIABETICS
Dr.Smriti Rastogi1, Dr.Narsingh Verma2
#0021
Telomere length of the gums of patients with diabetes mellitus in non-alcoholic fatty liver disease
Dmitry Emelyanov, Nataliya Emelyanova, Tatyana Petrushanko, Valentina Galchinska, Tatyana Bondar, Olena Otchenashenko1
#0022
Metabolic complications of highly active antiretroviral therapy in adult HIV-infected patients with heart failure: A 7-year prospective cohort study
Kevin Sheng-Kai Ma
#0024
Aldose Reductase inhibition by AT-001 Prevents Diabetic Cardiomyopathy Via Reducing Myocardial Fatty Acid Oxidation Rates
Keshav Gopal1,2, Qutuba G Karwi1, S. Amirhossein Tabatabaei-Dakhili1,2, Cory S. Wagg1, Riccardo Perfetti3, Ravichandran Ramasamy4, John R Ussher1,2, Gary D Lopaschuk1
#0025
Cardio-metabolic factors associated to mortality in patients with COVID-19
Camey Eduardo, M.D., Arauz Guillermo, M.D., Cárcamo Alejandra, M.D, Celis Grecia, M.D.
#0026
Trends in Hyperinsulinemia Among U.S. Adults without Diabetes: A Joinpoint Analysis
James R. Churilla, PhD, MPH, Tammie M. Johnson, DrPH, MPH, Michael R. Richardson, Ph.D., MSH, MS, and Ralph G. Cosentino, MSH
#0027
Leveraging Automated Machine Learning to provide NAFLD screening diagnosis: Proposed machine learning models
Ali Haider Bangash*(1),(2)§, Arshiya Fatima(1)§, Saiqa Zehra(1)§, Ali Haider Shah(1)§, Syed Mohammad Mehmood Abbas(1)§, Syed Muhammad Qasim Shah(1)§, Ayesha Khalid(1)§, Hashir Fahim Khawaja(1)§, Adil Baloch(1)¶, Ali Danish Khan(1)¶, Aliya Ali(1)¶, Aymen Yunus(1)¶, Farhan Faisal(1)¶, Gulfam Jameel(1)¶, Kashaf Mushtaq(1)¶, Maryam Naveed Abbasi(1)¶, Mehwish Nawaz(1)¶, Mishal Bilal(1)¶, Muhammad Ashraf(3)¶, Musa Kamil(1)¶, Noor Ayesha*(1)¶, Rabia Mohsin(1)¶, Sadaf Khalid(1)¶, Saleha Yurf Asghar(1)¶, Syeda Tatheer Zahra(4)
#0028
Is coffee a potential appetite suppressant?
M. Sedanur MACİT, Eda KÖKSAL
#0029
The Association Between Adiponectin and Myocardial Infarction in Patients with Nonalcoholic Fatty Liver Disease
Tulio Loyola Correa, Mariana Sandoval Terra Campos Guelli
#0030
Fat mass paradox and carotid intima-media thickness progression: A longitudinal study from childhood through young adulthood
Andrew O. Agbaje MD, MPH1, Alan R. Barker PhD2, Tomi-Pekka Tuomainen MD, PhD1
#0031
Adolescence arterial stiffness precedes elevated blood pressure in young adulthood: The ALSPAC birth cohort
Andrew O. Agbaje MD, MPH1, Alan R. Barker PhD2, Tomi-Pekka Tuomainen MD, PhD1
#0032
Longitudinal and bi-directional associations of arterial stiffness with general and central fat mass from adolescence through young adulthood: The ALSPAC Study
Andrew O. Agbaje MD, MPH1, Alan R. Barker PhD2, Tomi-Pekka Tuomainen MD, PhD1
#0033
Omega-3 Fatty Acids intervention and DASH Diet Ameliorates Metabolic profiling in Patients with Diabetes Mellitus Type 2
Faisal Ali , Ahmad Al-Junaid, Ali Mohamed Saleh
#0034
BODY WEIGHT CHANGE IN HYPERCOLESTROLEMIC RATS MODEL AFTER INTERVENTION WITH AVOCADO (Persea americana Mill) JUICE
Muhammad Luthfi Adnan1, Raihan Lucky Buana1, Dimas Agus Cholili1, Hilmi Ardian Sudarto1, Amalia Adityas Dyah Safitri1, Tiar Ramadhan1, Miranti Dewi Pramaningtyas1
#0035
Liraglutide in Treatment of Diabetes Mellitus Type 2: Systematic Review and Bibliometric Analysis Over The Last Two Decades
Manar Ahmed Kamal 1 , Raneem Mahmoud Al-Arawi 2
#0036
Vitamin D status and its Association with Atherogenic Index of Plasma in Young Subjects with PCOS
Vipan Talwar
#0037
Effects of bariatric surgery versus pharmacological treatment on oxidative stress in metabolic syndrome
Tomas Augusto Castillo1, Micaela Milagros Rossi1, María de la Paz Scribano Parada1, Franco Signorini1,2, Ismael Fonseca3, María del Carmen Baez1.
#0038
The Effect of Diabetes Mellitus and Revascularization Status on Cardiorespiratory Fitness in Multi-vessel Acute Coronary Syndrome Patients
Hye-Su Yun1, Hee-Jung Lee1, Cheol Hyun Lee1, Yun-Kyeong Cho1, Hyuck-Jun Yoon1, Jin-Wook Chung1, Hyungseop Kim1, Chang-Wook Nam1, Seung-Ho Hur1, Jong-Chan Youn2, and In-Cheol Kim1*
#0042
Polymorphism of apolipoprotein E in children with metabolic diseases of the biliary tract
Belousova OYu, D.Med.Sc., Shutova OV, Pavlenko NV, Solodovnichenko IG, Вabadzhanian OM, Voloshyna LG, Hanzii OB, Abbas Kaafarani, Savytska KV, PhD., Kazaryan LV
#0043
Role of SORT1 gene in patients with Coronary Artery Disease.
Shelly aggarwal, Rajiv Narang, Daman Saluja, Kamna Srivastava
#0044
TAS2R38 taste receptor gene and metabolically unhealthy obesity
Aleksandr Abaturov, Anna Nikulina, Dmitriy Nikulin
#0045
Nitrogen oxide metabolism in the liver under conditions of systemic inflammatory response
Mykytenko А.О., Akimov О.Y., Matsytska Y.K., Neporada K.S.
#0046
ASSOCIATIONS BETWEEN PHYSICAL ACTIVITY AND RISK FACTORS FOR TYPE II DIABETES IN PREDIABETIC ADULTS
Rukia Yosuf
#0047
Impact of COVID-19 outbreak in health care of people with type 2 diabetes: evidence from a cross-sectional study in Albania
1 Fatjona Kamberi, 1Jerina Jaho, 3 Enkeleda Sinaj, 3Vjollca Ndreu. 3Ilirjana Zekja
#0048
Psoriasis in childhood and metabolic syndrome : a systematic review
Mariana Sandoval Terra Campos Guelli
#0049
Diet-induced obesity and NASH aggravate SARS-CoV-2 infection in golden Syrian hamsters
François Briand(1), Valentin Sencio(2,3), Thierry Sulpice(1) and François Trottein(2,3)
#0050
Alpha-lipoic acid as an alternative treatment for diabetic polyneuropathy ?
DEMMOUCHE abbassia; Bekhadda Hadjer, Menadi Noreddine, Bouazza Sofiane, Mai Hicham
#0051
Effects of metformin and lutheinizing hormone receptor agonists on steroidogenesis and spermatogenesis in rats with type 2 diabetes with their separate and combined administration
A.A. Bakhtyukov, K.V. Derkach, A.M. Stepochkina, V.N. Sorokoumov, L.V. Bayunova, I.A. Lebedev, A.O. Shpakov
#0052
Evaluation of metabolic syndrome, insulin secretion and insulin resistance in adolescents with overweight and obesity
Yethindra Vityala1; Tugolbai Tagaev2; Altynai Zhumabekova3; Sagynali Mamatov4
#0053
Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Severe Hypertriglyceridemia (SHTG) – Initial Baseline data from an Ongoing Phase 2 Study
Deepak L. Bhatt, MD, MPH, John J.P. Kastelein, MD, Teresa Parli, MD, R Will Charlton, MD, Cynthia L Hartsfield, PhD, Shibao Feng, PhD, Hank Mansbach, MD, Harold Bays, MD
#0054
Partial Reversal of T2D Through Dietary Manipulation
LK Shankhdhar, Kshitij Shankhdhar, Smita Shankhdhar
#0055
Co-administration of metformin and intranasal insulin more effectively restores the metabolic and hormonal parameters in diabetic rats in comparison with monotherapy
Anna Mikhailovna Stepochkina, Kira Viktorovna Derkach, Andrey Andreevich Bakhtyukov, Vera Mikhailovna Bondareva, Natalia Evgenievna Basova, Alexander Olegovich Shpakov
#0056
Effect of Remote Ischemic Conditioning in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
Nehal Nasr Mahmoud 1,2’, Fatma Mohamed Sayed 1,2’, Manar Ahmed Kamal 2,2’ Amal suliman alttaira 3,2’ Sarah Makram Elsayed 4,2’, Mais Hutham Sabri 5,2’, Ahmed Alaa AbdelAzim6,2’, Fatma A. Monib7,2’, Sondos Hussien Osman 8,2’, Massara ben ahmeida 8,2’, Maisa Saleh Assiwi 9,2’
#0057
BIO89-100 Demonstrated Robust Reductions in Liver Fat, Improved Metabolic Parameters, Favorable Tolerability and Potential for Weekly (QW) or Every 2 Weeks (Q2W) Dosing in a Phase 1b/2a Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in NASH.
Juan Pablo Frias, MD, Grisell Ortiz-Lasanta, MD, Cynthia L Hartsfield, PhD, Leo Tseng, PhD, R William Charlton, MD, Hank Mansbach, MD, Maya Margalit, MD, Rohit Loomba, MD
#0058
The utility of novel CGM metrics in the LGA newborn prediction in women with type 1 diabetes – assessment of the cut-off values.
Rafal Sibiak1,2, Beata Mrzewka-Rogacz1, Pawel Gutaj1, Urszula Mantaj1, Ewa Wender-Ozegowska1
#0059
Hepatic Steatosis, Fibrosis, and Insulin Resistance: Implications for Therapy
Olga Lavrynenko 1,2, MD, PhD, Muhammad Abdul-Ghani1, MD, PhD , Hector Santos, MD 2andRalph DeFronzo1, MD
#0060
Adolescence arterial stiffness precedes insulin resistance in young adulthood: A 7-year temporal longitudinal findings using cross-lagged structural equation model
Andrew O. Agbaje, MD, MPH1, Alan R. Barker, PhD2, Tomi-Pekka Tuomainen, MD, PhD1
#0061
The association between sialic acid and type 2 diabetes in older patients
Gianina Ioana Constantin1, Catalina Monica Pena1, Simona Opris1
#0062
Fulminant Insulin-Dependent Diabetes in Patient with Squamous Cell Carcinoma on Nivolumab Presenting as Severe Diabetic Ketoacidosis
Nauman A Jadoon, M Adnan Afzal
#0063
Relations between food intake, weight status and cardio-metabolic disturbances in area representative group
Andreea Morosanu, Magdalena Morosanu
#0064
Evaluation of the effect of β-Caryophyllene on oxidative stress in BALB / c mice with streptozotocin-induced diabetes
Paola T. Villalobos-Gutierrez, Maria de Jesus Romero-Hernandez, Oscar Gutierrez Coronado
#0065
Modulation of TREM-1, Arginase and Nitric Oxide Levels under Diabetic Conditions in Macrophages
Alia Shatanawi 1, Ebaa M. Al Zayadneh 1, Tahira Lemtalsi, Abdelrahman Y. Fouda 2, Ruth B. Caldwell 2, R. William Caldwell 2
#0066
Integration of genetic colocalizations with physiological and pharmacological perturbations identifies cardiometabolic disease genes
Michael J. Gloudemans1,2*, Brunilda Balliu3*, Daniel Nachun4,5, Matthew G. Durrant4, Erik Ingelsson6, Martin Wabitsch7, Thomas Quertermous6,8, Stephen B. Montgomery2,4, Joshua W. Knowles6,8,9, Ivan Carcamo-Orive6,8†
#0067
Recording of the spinal neurovascular response triggered by a non-noxious peripheral nerve stimulation in patients with diabetes mellitus
Juan Esteban Oyarzún1,2, Raul Caulier Cisterna1,2, Juan Pablo González Appelgren1, Antonio Eblen-Zajjur A3; Sergio Uribe1,2,4
#0068
Prevalence trends in obesity defined by the Relative Fat Mass (RFM) index among adults in the United States: 1999−2018
Orison O. Woolcott a,b Till Seuring c
#0069
Diabetes knowledge and associated factors in rural Eastern Cape, South Africa: A cross sectional study
Eyitayo Omolara Owolabi
#0070
Knowledge and practice of foot care and examination among individuals with diabetes in rural Eastern Cape Province, South Africa
Eyitayo O. Owolabi, Kathryn M. Chu
#0071
The Association Between Gestational Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Systematic Literature Review
Mariana Sandoval Terra Campos Guelli, Tulio Loyola Correa, Andreza Brandão da Silva, Carina de Oliveira Lopes, Cristiane Freitas Couto
#0072
The influence of metformin on the rate of Covid-19 vaccination among diabetes type 2 patients in Poland
Daniel Bałut, Marcin Kleibert, Patrycja Małgorzata Bąk, Jakub Zieliński , Beata Mrozikiewicz-Rakowska
#0073
Evaluation of response to clopidogrel therapy in patients with acute coronary syndrome by platelet aggregation method
Liana Suciu1, Maamoun Rebai2, Maria Suciu1, Valentina Buda3, Hanene Ghozzi Allouche4